Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A comprehensive medical assessment is essential before starting treatment
Regulatory guidelines from the Medicines and Healthcare products Regulatory Agency state that only people classified as clinically obese, with a Body Mass Index (BMI) of more than 30, or those who are overweight (BMI of 27-30) with at least one weight-related health condition such as high blood pressure or type 2 diabetes, will be eligible to receive the drug
There are no clinical trials on this approach it's based on pharmacokinetic modelling and community experience
Pocket friendly cost
One study compared the effects of Semaglutide and diabetes medication Sitagliptin on blood sugar levels
US$ 24.91
US$ 26.90
US$ 22.30
